Key Publications
Teede HJ, Khomami MB, Morman R, Laven JSE, Joham AE, Costello MF, Patil M, Rees DA, Berry L, Cree MG, Zhao H, Norman RJ, Dokras A, Piltonen T; Global Name Change Consortium. Polyendocrine metabolic ovarian syndrome, the new name for polycystic ovary syndrome: a multistep global consensus process. Lancet. 2026 May 12:S0140-6736(26)00717-8. doi: 10.1016/S0140-6736(26)00717-8. Epub ahead of print. PMID: 42119588.
Piltonen TT, Kuusiniemi E, Teede H; WENDY Research Group study group. Ovarian Cysts in Polycystic Ovary Syndrome. JAMA Intern Med. 2026 May 11:e261370. doi: 10.1001/jamainternmed.2026.1370. Epub ahead of print. PMID: 42113530; PMCID: PMC13162137.
Piltonen TT, Ohtamaa M, Arffman RK, Vuokila L, Hurskainen E, Männikkö M, Huilaja L, Sinikumpu SP, Rautio T, Kilpivaara K, Jokelainen J, Kiviniemi E, Pinola P, Törnävä M, Komsi E, Kangasniemi MH, Rajecki M, Luiro K, Kinnunen J,Savukoski SM. Women’s health study (WENDY) – a protocol of a population-based study assessing gynecological and metabolic health in women in their mid-30s. Am J Epidemiol. 2024 Aug 3:kwae230. doi: 10.1093/aje/kwae230. Epub ahead of print.PMID: 39098824
Stener-Victorin E, Teede H, Norman RJ, Legro R, Goodarzi MO, Dokras A, Laven J, Hoeger K, Piltonen TT. Polycystic ovary syndrome. Nat Rev Dis Primers. 2024 Apr 18;10(1):27. PMID: 38637590 doi: 10.1038/s41572-024-00511-3.
Teede HJ, Tay CT, Laven J, Dokras A, Moran LJ, Piltonen TT, Costello MF, Boivin J, M Redman L, A Boyle J, Norman RJ, Mousa A, Joham AE; International PCOS Network. Recommendations from the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome. J Clin Endocrinol Metab. 2023 Sep 18;108(10):2447-2469. doi: 10.1210/clinem/dgad463. PMID: 37580314; PMCID: PMC10505534.
Luyckx L, Myllykangas M, Saarela U, Virtanen N, Hurskainen E, Savolainen A, Ollikainen N, Norlén AK, Ohlsson C, Poutanen M, Velde GV, Arffman RK, Prunskaite-Hyyryläinen R, Vriens J, Piltonen TT. Prenatally androgenized PCOS mice have ovary-independent uterine dysfunction and placental inflammation aggravated by high-fat diet. Sci Adv. 2025 May 9;11(19):eadu3699. doi: 10.1126/sciadv.adu3699. Epub 2025 May 9.
Luyckx L, Wei M, Saarela U, Myllykangas M, Kinnunen J, Arffman R, Lie Fong S, Vriens J, Vankelecom H, Piltonen TT. PCOS endometrium-derived epithelial organoids as a novel model to study endometrial dysfunction. Hum Reprod. 2025 Jun 11:deaf113. doi: 10.1093/humrep/deaf113. Epub ahead of print. PMID: 40499150.
Kujanpää L, Arffman RK, Pesonen P, Hurskainen E, Järvelin MR, Franks S, Tapanainen JS, Morin-Papunen L, Piltonen TT. Polycystic ovary syndrome presents as a multimorbid condition by age 50: birth cohort linkage to national register data. Eur J Endocrinol. 2024 Jun 5;190(6):409-420. doi: 10.1093/ejendo/lvae057. PMID: 38781435
Pesonen E, Nurkkala M, Ollila MM, Hurskainen E, Morin-Papunen LC, Jämsä T, Korpelainen R, Niemelä M, Piltonen TT. Women with polycystic ovary syndrome are at risk of emotional and uncontrolled eating at midlife: a population-based cohort study. Fertil Steril. 2025 Mar;123(3):383-393.doi: 10.1016/j.fertnstert.2024.09.042. Epub 2024 Sep 29.
Virtanen N, Saarela U, Karpale M, Arffman RK, Mäkelä KA, Herzig KH, Koivunen P, Piltonen T. Roxadustat alleviates metabolic traits in letrozole-induced PCOS mice. Biochem Pharmacol. 2024 Nov;229:116522. doi: 10.1016/j.bcp.2024.116522. Epub 2024 Sep 6. PMID: 39245394
Haapakangas SM, Koskenkari NVS, Hurskainen EL, Arffman RK, Ollila MM, Piltonen TT. Neck circumference as a metabolic health marker among women with polycystic ovary syndrome (PCOS): a systematic review and meta-analysis. Int J Obes (Lond). 2025 Apr 21. doi: 10.1038/s41366-025-01753-1.